Access Biotechnology — Full Portfolio

Arvinas develops targeted protein degradation therapies using its PROTAC (PROteolysis TArgeting Chimeras) platform, which harnesses the body's natural protein disposal system to degrade disease-causing proteins.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)Manuel Litchman(Executive Officer, Director)

BoardStephen Squinto(Director)inLiam Ratcliffe(Director)Tim Shannon(Director)inKush Parmar(Director)

Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsNextech InvestRA CapitalSolasta Ventures+1 more

Advancing potentially best-in-class therapeutics for myeloproliferative neoplasms.

BiotechCopenhagen, US

Christopher Cain(Director)Garrett Winslow(Executive Officer)Carl Goldfischer(Director)Lori Firmani(Executive Officer)Peter Harwin(Director)Amit Munshi(Director)

Co-investorsBay City CapitalEIR Ventures

Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need.

BiotechHealthtech

John Quisel(Chief Executive Officer)Jean Franchi(Chief Financial Officer)Jonathan Yu(Chief Operating Officer)Will Savage(Chief Medical Officer)Pamela Stephenson(Chief Commercial Officer)Steve Caffé(Chief Regulatory Officer)

Co-investorsAtlas VentureBain Capital Life SciencesForesite CapitalFrazier Life SciencesOrbiMed

Hemab is a biotechnology company developing targeted prophylactic therapies for people with serious bleeding and blood coagulation disorders that lack adequate treatment options.

BiotechHealthtech

Co-investorsAvoro Capital AdvisorsHealthCapNovo HoldingsSofinnova Partners

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)Samuel Agresta(Executive Officer)Dylan Hartley(Executive Officer)Nicholas Saccomano(Executive Officer, Director)Wendy Johnson(Executive Officer)

BoardIsaac Manke(Director)in

Co-investorsRiverVest Venture PartnersAbingworthACORN BIOVENTURESBoulder VenturesNew Enterprise Associates (NEA)

Spyre Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunology, aiming for more complete disease control, greater durability, and simpler treatment.

BiotechHealthtech

Co-investorsAisling Capital

Upstream Bio is a clinical-stage biotechnology company developing verekitug, an antagonist that targets the TSLP receptor to inhibit pro-inflammatory signaling.

BiotechHealthtech

Rand Sutherlandin

Co-investorsBain Capital Life SciencesDecheng CapitalOrbiMedTCG CrossoverVenrock Healthcare Capital Partners

Zura Bio is a clinical-stage biotechnology company developing antibody therapies for autoimmune diseases using a dual antagonism strategy that targets multiple immune pathways simultaneously.

BiotechHealthtechLa Jolla, US

Someit Sidhu(Executive Officer, Director)Neil Graham(Director)Gary Whale(Chief Technology Officer)Garry Neil(Director)Michael Howell(Executive Officer)Christopher Cabell(Executive Officer)

Co-investorsTMG Ventures

Santa Ana Bio is a biotech company developing engineered antibody therapeutics that target the immune pathways and cells driving autoimmune and inflammatory diseases.

AI & Machine LearningBiotechHealthtechAlameda, US

Peter Emtage(Founder & CEO)inAlexander Rudensky(Scientific Founder)Richard Flavell(Scientific Founder)Graham Lord(Scientific Founder)Ansuman Satpathy(Scientific Founder)Newman Yeilding(Chief Medical Officer)in

Co-investorsVersant VenturesAndreessen HorowitzGV (Google Ventures)RTW Investments L.P.TPG

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight VenturesSolasta VenturesBios PartnersCorrelation VenturesFemHealth VenturesHatteras Venture Partners+2 more

Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.

BiotechChapel Hill, US

Robin Walker(Executive Officer)Christopher Courts(Executive Officer)Jorge Bartolome(Executive Officer, Director)

BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)

Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Maverick CapitalSaturn PartnersViking Global Investors

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.

BiotechHealthtechSouth San Francisco, US

Jeremy Bender(Executive Officer, Director)

BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)Daniel Becker(Director)

Co-investorsAtlas VentureCanaan PartnersRA CapitalThe Column Group

Co-investorsAvoro Capital Advisors

The site presents corporate and investor news relating to Novo Nordisk, a pharmaceutical company, including financial reports and clinical trial results for products such as GLP-1 medicines and the hemophilia A treatment denecimig (Mim8).

BiotechHealthtech

Co-investorsBain Capital Life Sciences

Draig Therapeutics is a clinical-stage biotech company developing neuromodulator therapies for neuropsychiatric disorders such as major depressive disorder.

BiotechDeep TechDigital Health

Co-investorsCanaan PartnersSanofi VenturesSR One Capital ManagementSV Health InvestorsBritish Business BankJanus Henderson Investors

BiotechSan Diego, US

Arthur T Suckow(Executive Officer)Arthur Suckow, Ph.D.(Founder)in

Co-investorsExSight VenturesRA Capital

BiotechMedical DevicesNew Haven, US

Scott Phillips(Executive Officer)

BoardTim Shannon(Manager)inLiam Ratcliffe(Manager)

Co-investorsCanaan PartnersConnecticut InnovationsFrazier Life SciencesRA CapitalTaiho Ventures, LLCVida Ventures

Khanda is a biotech company builder that translates validated and emerging biological insights into new biotechnology companies focused on orthogonal, combination-based therapeutic approaches.

Biotech

Latigo Bio is a clinical-stage biopharmaceutical company developing non-opioid pain medicines intended to block pain transmission without addiction risk.

BiotechHealthtechThousand Oaks, US

Nima Farzan(Executive Officer, Director)Tim Lugo(Executive Officer)

BoardBeth Seidenberg(Director)inJim Tananbaum(Director)Deborah Palestrant(Director)inKevin Raidy(Director)

Co-investorsForesite CapitalKern Capital, LLCSanofi Ventures5AM VenturesWestlake Village BioPartners

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue.

BiotechHealthtechMedical Devices

Co-investorsAtlas VentureNextech InvestForbionRA Capital

Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

Cambridge, US

Co-investorsDigitalis VenturesSanofi Ventures

Harnesses cutting-edge technologies to design exquisitely selective small molecule therapeutics.

Co-investorsBain Capital Life SciencesLightstone VenturesPfizer Venture InvestmentsRA CapitalSV Health Investors

BiotechCambridge, US

Jo Viney(Executive Officer)Rahul Kakkar(Executive Officer, Director)Anthony Coyle(Executive Officer, Director)Christopher Fuglesang(Director)Donald Frail(Director)Daniel Becker(Director)

Co-investorsPolaris PartnersVersant Ventures

Perfuse Therapeutics is a biotechnology company developing a therapy to improve blood flow to the retina, targeting ocular diseases such as glaucoma and diabetic retinopathy.

BiotechMedical DevicesSan Francisco, US

BoardChristy Shaffer(Director)Chau Khuong(Director)inSevgi Gurkan(Executive Officer, Director, Promoter)in

Co-investorsCatalio Capital Management, LPHatteras Venture PartnersLAVLilly Asia VenturesOrbiMedHatteras

BiotechSouth San Francisco, US

MARTIN BABLER(Executive Officer, Director)

BoardPETER THOMPSON(Director)SRINIVAS AKKARAJU(Director)MICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)

Co-investorsMission BiocapitalSofinnova VenturesMission Bay CapitalNew Leaf Venture PartnersOrbiMedSamsara BioCapital

Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

Nancy Whiting(CEO)

Co-investorsNew Enterprise Associates (NEA)Westlake Village BioPartners

Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases.

BiotechMedical DevicesAlameda, US

Peter Emtage(Founder & CEO)inAlexander Rudensky(Scientific Founder)Richard Flavell(Scientific Founder)Graham Lord(Scientific Founder)Ansuman Satpathy(Scientific Founder)

BoardThomas Woiwode(Director)in

Co-investorsAndreessen HorowitzGV (Google Ventures)Versant Venture CapitalVersant Ventures

Talawar Therapeutics develops bispecific antibodies that combine two disease-driving pathways in a single therapy for greater and more durable treatment effect.

Biotech

Steve Migausky(Chief Legal and Administrative Officer)

Surrozen develops multifunctional antibody therapeutics that modulate the Wnt signaling pathway and other disease drivers, using a proprietary antibody-engineering platform.

BiotechHealthtech

Co-investorsThe Column Group

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)Peter Spargo(Executive Officer)Patrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsAisling CapitalAndera PartnersForesite CapitalFrazier Life SciencesNew Enterprise Associates (NEA)Sofinnova Partners+4 more

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases.

BiotechHealthtechMedical Devices

Bernard Ravina(Founder and Chief Executive Officer)Judy Dunn(President of Research & Development)Jessica Fees(Chief Financial Officer)Ariel D. Jasie(Chief Business Officer and General Counsel)Tushar Misra(Chief Technical Officer)

Co-investorsAtlas VentureFrazier Life SciencesAccess IndustriesCanaan Partners